Sam Altman invests in Merge Labs, a startup developing a non-invasive brain-computer interface to read thoughts without surgery, unlike Neuralink.
© Baltimorechronicle.com. All rights reserved.
Sam Altman invests in Merge Labs, a startup developing a non-invasive brain-computer interface to read thoughts without surgery, unlike Neuralink.
Independent news platform delivering sharp analysis and fresh perspectives on USA, world affairs, politics, economy, tech, health, and more. Stay informed, stay ahead.
© Baltimorechronicle.com. All rights reserved.